// App-Quantinova.ai

M5253 2016 AHA : Higher Amount of Heparin Use is a Potential Independent Risk Factor for Cardiac Tamponade and Pericardial Effusion in the Periprocedural Period of Catheter Ablation for Atrial Fibrillation With DOACs Treatment

Researchers

Presenter

  • Tadashi Fujino

Principal Investigators

  • Masaya Shinohara

  • Hideki Koike

  • Hitomi Yuzawa

  • Takeya Suzuki

  • Hideyuki Hideyuki

  • Shunji Fukunaga

  • Kenzaburo Kobayashi

  • Takanori Ikeda

Medical Centers

  • Toho University Faculty of Medicine, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Arrhythmia

  • Cardiac tamponade

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

  • apixaban

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved